Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuroendocrine Tumors × vatalanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Sarcoma 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 von Hippel-Lindau Disease 1 Vipoma 1 Somatostatinoma 1 Solitary Fibrous Tumor, Pleural 1 Prostatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Mesothelioma, Malignant 1 Meningioma 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia 1 Insulinoma 1 Hemangiopericytoma, Malignant 1 Hemangioblastoma 1 Glucagonoma 1 Gastrointestinal Stromal Tumors 1 Gastrinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Islet Cell 1 Breast Neoplasms 1

Interventions

lutetium Lu 177 dotatate 15 Everolimus 10 Temozolomide 9 Nivolumab 8 Capecitabine 7 pembrolizumab 6 cabozantinib 5 Sunitinib 5 lanreotide 4 gallium Ga 68 dotatate 4 177Lu-octreotide, DOTA(0)-Tyr(3)- 4 telotristat ethyl 3 pazopanib 3 lenvatinib 3 avelumab 3 Octreotide 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Injections 3 Etoposide 3 Cyclophosphamide 3 Carboplatin 3 Bevacizumab 3 surufatinib 2 sintilimab 2 fosbretabulin 2 fludarabine 2 Specimen Handling 2 Positron Emission Tomography Computed Tomography 2 Pemetrexed 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00590343 2011-06-29

PTK787

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡